Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRM8 antisense RNA 1 (GRM8-AS1) is a long non-coding RNA gene that is transcribed in the antisense direction relative to the GRM8 gene, which encodes the metabotropic glutamate receptor 8. While the specific biological roles of GRM8-AS1 are not well characterized, antisense RNAs typically act to regulate the expression of their overlapping sense gene through mechanisms such as transcriptional interference, RNA duplex formation, and modulation of mRNA stability or translation. There are currently no direct associations of GRM8-AS1 with diseases, nor is it considered a direct target for approved drugs or therapeutic intervention[2][3]. The related protein product of GRM8 is a well-studied G protein-coupled receptor with roles in neurotransmission and disease[1][7]. GRM8-AS1 is not a receptor, enzyme, or common drug target. If the intent is to find information on "GRM8" (glutamate metabotropic receptor 8), refer to entries for the receptor itself, which fits canonical therapeutic target profiles[1][7]. The present entry refers strictly to the non-coding RNA.
Not applicable; no drugs target GRM8-AS1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRM8 antisense RNA 1 (GRM8-AS1).